Preventing re-infections, more variants, and a prolonged pandemic By Daniel R. Lucey MD, MPH, FIDSA Emerging data since mid-January from South Africa and northern Brazil signal it is imperative to develop multivalent COVID vaccines (bivalent, trivalent, quadrivalent) for international use. An alternative strategy that is unlikely to succeed internationally is monovalent “booster” vaccines containing either […]
HIV
Steeped in inequities that include formidable barriers to basic health services for multitudes of its most vulnerable, marginalized and neglected people, the country leading global HIV […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
With 2018 data showing highest incidence acute flaccid myelitis since monitoring began, officials say awareness, recognition of rare life threatening condition will be crucial to early […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]